| Literature DB >> 29066707 |
Man Lai1, Xiuqun Zhang2, Qunhui Li1, Caiping Guo1, Yulin Zhang1.
Abstract
BACKGROUND Diffuse large B-cell lymphoma (DLBCL) accounts for the large majority of AIDS-related non-Hodgkin's lymphoma (NHL). DLBCL usually arises in lymph nodes, presenting as a painless rapid swelling mass in the neck, armpit, or groin. CASE REPORT Here, we report a case of DLBCL that needed only 3 months to develop a tumor 20×15 cm in diameter in the right groin and even caused scrotum swelling and lower-extremity edema. Furthermore, this case of DLBCL had developed other 3 subcutaneous tumors in the chest wall and their diameters were 16×9 cm, 7×7 cm, and 3×3 cm. A thoracic computed tomography (CT) scan presented with bilateral pleural effusion and the chest wall tumors with rib lesions. CONCLUSIONS It is rare that a DLBCL needed only 3 months to develop a tumor 20×15 cm in diameter and even caused scrotum swelling and unilateral lower-extremity edema due to the large mass located in the right groin. Furthermore, it is extremely rare that this lymphoma infiltrated the chest wall and even resulted in rib lesions.Entities:
Mesh:
Year: 2017 PMID: 29066707 PMCID: PMC5667585 DOI: 10.12659/ajcr.905904
Source DB: PubMed Journal: Am J Case Rep ISSN: 1941-5923
Figure 1.(A–F) Morphological presentations of the tumors.
Laboratory test results on admission.
| White blood cell counts (109/L) | 7.12 | 3.5–9.5 | High-sensitivity C-reactive protein (mg/L) | 46.0 | 0–10 |
| Neutrophils percentage (%) | 61.9 | 40–75 | Procalcitonin (ng/ml) | <0.05 | <0.1 |
| Lymphocyte percentage (%) | 31.6 | 20–50 | Anti-human immunodeficiency virus antibody | Positive | Negative |
| Hemoglobin (g/L) | 130.0 | 130–175 | Plasma (1,3) beta-D-glucan (pg/mL) | 78.4 | <60 |
| Platelets (109/L) | 314 | 125–350 | Carcino-embryonic antigen (ng/ml) | 0.456 | 0–4.7 |
| Blood urea nitrogen (mmol/L) | 5.54 | 2.9–8.2 | Carbohydrate antigen 19-9 (U/ml) | 6.48 | 0–27 |
| Creatinine (μmol/L) | 73.9 | 59–104 | Carbohydrate antigen 72-4 (U/ml) | 6.59 | 0–6.9 |
| Alanine transarninase (U/L) | 21.9 | 9–50 | Carbohydrate antigen 125 (U/ml) | 62.10 | 0–35 |
| Glutamic-oxal acetic transaminase (U/L) | 25.4 | 15–40 | Carbohydrate antigen 15-3 (U/ml) | 6.11 | 0–25 |
| Total bilirubin (µmol/L) | 8.2 | 5–21 | Neuron-specific enolase (ng/ml) | 49.36 | 0–16.3 |
| Direct bilirubin (µmol/L) | 3.1 | <7 | Cytokeratin protein fragment 21-1 (ng/ml) | 5.940 | 0–3.3 |
| Albumin (g/L) | 41.0 | 40–55 | Total prostate-specific antigen (ng/ml) | 0.256 | 0–2.0 |
| CD4 cell counts (cells/μL) | 411.0 | 544–1212 | Free prostate-specific antigen (ng/ml) | 0.074 | 0–0.934 |
| Erythrocyte sedimentation rate (mm/hr) | 17.0 | 0–15 | Ferritin (ng/ml) | 441.10 | 30–400 |
Figure 2.CT presentations of the tumors. (A, B) A thoracic CT scan showed right chest wall tumors (the sword denotes chest wall tumor). (C) A thoracic CT scan showed right chest wall tumors with rib lesions and right pleural effusion (the sword denotes chest wall tumor with rib lesion). (D) A pelvic CT showed right inguinal mass (the sword denotes right inguinal mass). (E) A leg CT scan showed right inguinal mass (the sword denotes right inguinal mass). (F) A leg CT scan showed right subcutaneous soft-tissue swelling.
Figure 3.Pathological morphology of the right groin mass biopsy. The morphology showed the following immunohistochemistry results: Ki67(≥95% +), P53(+), CD20(+++), CD3(minor+), Vimentin(+++), CD79a(+++), Bcl-2(−), Bcl-6(+), and CD10(++).